Neuroone Medical Technologies (NMTC) Market Capitalization (2017 - 2026)

Neuroone Medical Technologies (NMTC) has reported Market Capitalization for 10 consecutive years, with $26.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 21.72% year-over-year to $26.5 million; the trailing twelve-month figure through Jun 2026 stood at $26.5 million (down 21.72% YoY), and the FY2025 full-year result was $35.7 million, up 16.96% from the prior year.
• Market Capitalization fell to $26.5 million in Q2 2026 per NMTC's latest filing, from $40.1 million in the prior quarter.
• Across five years, Market Capitalization topped out at $40.1 million in Q1 2026 and bottomed at $13.3 million in Q2 2022.
• Historically, Market Capitalization has averaged $27.4 million across 5 years, with a median of $26.9 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization tumbled 83.27% in 2022, then surged 101.34% in 2023.
• Over 5 years, Market Capitalization stood at $19.5 million in 2022, then soared by 101.34% to $39.2 million in 2023, then sank by 35.08% to $25.5 million in 2024, then soared by 50.03% to $38.2 million in 2025, then sank by 30.76% to $26.5 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $26.5 million, $40.1 million, and $38.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.